Dr. Lal Pathlabs Ltd.

NSE: LALPATHLAB | BSE: 539524 | ISIN: INE600L01024 | Industry: Healthcare Services
| Mid-range Performer
3127.7000 -41.00 (-1.29%)
NSE Oct 03, 2025 15:31 PM
Volume: 50,439
 

3127.70
-1.29%
ICICI Securities Limited
Dr Lal’s Pathlabs’ Q1 volume growth at 2.5% was impacted to some extent due to seasonality. Favourable test mix and traction in Swasthfit improved realisation per patient by 8.5% to INR 789 and aided gross margin expansion of 181bps YoY.
Dr. Lal Pathlabs Ltd. has an average target of 3111.40 from 5 brokers.
More from Dr. Lal Pathlabs Ltd.
Recommended